Tag: patients

Posted on

[Easyhalers in practice for treating patients with asthma].

Related Articles

[Easyhalers in practice for treating patients with asthma].

Ter Arkh. 2013;85(3):98-101

Authors:

Abstract
A comparative investigation was conducted to study the therapeutic effect of using two powder inhalers (the new-generation device–an easyhaler as well as an aerolyser inhaler) in daily practice for treating patients with moderate asthma. It showed the pharmacological equivalence, efficiency, and safety of applying a combination of the easyhalers budesonide and formoterol, as well as the simplicity and convenience to use the inhalers of this type.

PMID: 23720852 [PubMed – in process]

View full post on pubmed: asthma

Posted on

Asthma Patients may Benefit from Some Ginger Components – TopNews United States


Daily News & Analysis

Asthma Patients may Benefit from Some Ginger Components
TopNews United States
"These data show that ginger constituents 6-gingerol, 8-gingerol and 6-shogaol act synergistically with the beta -agonist in relaxing ASM, indicating that these compounds may provide additional relief of asthma symptoms", said Elizabeth Townsend, PhD …
Ginger may help alleviate asthma symptomsDaily News & Analysis

all 2 news articles »

View full post on asthma – Google News

Posted on

Experimental asthma drug helps untreatable patients in study – CBS News


CBS News

Experimental asthma drug helps untreatable patients in study
CBS News
Asthma suffers who aren't helped by existing medications may have reason to breathe a sigh of relief. An experimental drug called dupilumab was shown to reduce asthma attacks and helped boost lung function for people with moderate to severe asthma …
New drug could reduce asthma attacks by 87 percentFox News
Experimental drug touted as potential game changer for asthma sufferersSyracuse.com (blog)
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changerReuters
Forbes –SheKnows.com –Science Daily (press release)
all 25 news articles »

View full post on asthma – Google News

Posted on

Boehringer Ingelheim’s tiotropium shows promising results in patients with … – News-Medical.net

Boehringer Ingelheim's tiotropium shows promising results in patients with …
News-Medical.net
Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society …
Phase III results: tiotropium* Respimat® effective in symptomatic asthma …EON: Enhanced Online News (press release)
Boehringer Ingelheim reports positive data from symptomatic asthma trialsZenopa

all 3 news articles »

View full post on asthma – Google News

Posted on

Phase III Study: Tiotropium Effective In Symptomatic Asthma Patients – Science 2.0 – Science 2.0

Phase III Study: Tiotropium Effective In Symptomatic Asthma Patients – Science 2.0
Science 2.0
Tiotropium delivered by the Respimat(R) Soft Mist(TM) Inhaler (SMI) increases time to first severe exacerbation and first episode of asthma worsening across a broad spectrum of patients who remain symptomatic despite at least inhaled corticosteroids …
Phase III results: tiotropium(*) Respimat(R) effective in symptomatic asthma …Wall Street Journal (press release)
Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a …PR Newswire (press release)

all 4 news articles »

View full post on asthma – Google News

Posted on

New Asthma Drug Generates Excitement For Patients — And Its Maker – Forbes

New Asthma Drug Generates Excitement For Patients — And Its Maker
Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough and give yet another boost to Regeneron Pharmaceuticals, the company developing it, which has seen its shares rise 376% in the past two years, …
Regeneron, Sanofi asthma drug seen as potential game changerReuters
Monoclonal antibody appears effective and safe in asthma Phase IIa trialScience Codex
Sanofi, Regeneron Report Publication Of Phase 2a Results Of Dupilumab In …RTT News
MarketWatch (press release)
all 5 news articles »

View full post on asthma – Google News

Posted on

Iraq blocks entry of oxygen containers for Camp Liberty’s asthma patients – NCR-Iran.org (press release)


NCR-Iran.org (press release)

Iraq blocks entry of oxygen containers for Camp Liberty's asthma patients
NCR-Iran.org (press release)
NCRI – Continuing their imposition of inhumane restrictions against Liberty residents, forces under the command of the Iraqi Prime Ministry have been preventing the entry of oxygen containers – purchased by the residents at their own cost – for acute …

View full post on asthma – Google News